Enhanced DC maturation in tumor-draining lymph nodes (Fig. 11g) and elevated CD8+/CD4+ memory T cell populations (Fig. 11h) confirmed sustained immune memory activation, underscoring the nanovaccine’s capacity to prevent recurrence and metastasis. The gene discussed is CD4; the disease is neoplasm.